zoom_in Click to enlarge

Michael J. Zinner

▲ ▼

description Michael J. Zinner Overview

Michael J. Zinner is a general surgeon specializing in gastrointestinal surgical oncology. He is affiliated with Brigham and Women’s Hospital where he has led significant research and clinical advancements within this field. His expertise focuses on complex procedures related to the digestive system and cancers affecting these organs.

This work primarily benefits patients requiring specialized care for conditions like colorectal cancer, esophageal cancer, and other GI malignancies.

help Michael J. Zinner FAQ

What is Michael J. Zinner's medical specialty?

Dr. Michael J. Zinner is a prominent general surgeon who specializes in gastrointestinal surgical oncology. His expertise focuses heavily on complex surgical procedures related to the treatment of cancers of the digestive system. He has led significant research and clinical advancements within this highly specialized field.

Which hospital is Michael J. Zinner affiliated with?

Zinner is heavily affiliated with Brigham and Women’s Hospital in Boston, where he served as the Chief of Surgery for many years. During his tenure, he led significant clinical advancements in oncological surgery within the Harvard Medical School system. He also holds the title of Professor of Surgery at Harvard Medical School.

Did Michael J. Zinner contribute to medical literature?

Yes, in addition to his clinical advancements, Dr. Zinner is the co-editor of Maingot's Abdominal Operations, a highly influential reference textbook in the field of general surgery. He has authored hundreds of peer-reviewed papers focusing on surgical oncology. His textbooks are considered standard reading for surgical residents worldwide.

What institution did Michael J. Zinner help found?

Dr. Zinner was a driving force behind the establishment of the Miami Cancer Institute at Baptist Health South Florida. He left Boston to serve as the founding Executive Medical Director and Chief Executive Officer of the institute in the mid-2010s. He helped build the institute into a premier destination for cancer treatment in the southeastern United States.